Nanning Maple Leaf Pharmaceutical Co., Ltd., established on 1994-12-03, Business scope includes development,Study Chinese and Western patent medicines,pharmaceutical preparations,natural animal and plant extracts.(Drugs prohibited by the state are not allowed to be produced,Drugs restricted by the state are produced after being approved by the state pharmaceutical administration and other departments,Export products do not involve an export product license)(All projects involving permits shall be operated within the validity period of the permit).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada.

Xiamen Chaoyang Biological Engineering Co., Ltd., established on 2006-03-07, The scope of business includes the manufacture of chemical preparations;Chinese herbal medicine processing;Chinese patent medicine production;Biopharmaceutical Manufacturing;Sanitary materials and medical supplies manufacturing;Manufacturing of chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);marine services;Biotechnology Extension Services;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Own real estate business activities.

RaQualia began operations in July 2008 with a corporate mission, "They seek to bring people health and happiness through innovative new medications." Thanks to the support of all of their stakeholders, the company was listed on the JASDAQ Growth Market in July 2011. They have transformed RaQualia's R&D strategy, which is now based on the concept of "selection and concentration." They are now focusing on their core competencies in targeting ion channels in the fields of pain and gastrointestinal disease. In addition, they have made a strategic decision to relocate RaQualia's discovery processes to Nagoya University to better promote synergy effects with academia. With the Chubu region as their base, they are continuing with further efforts enhance their capabilities in drug discovery, improve shareholder value, and achieve financial stability by promoting licensing activities and alliance management with their corporate partners. They will continue to work tirelessly in providing patients with innovative medicines sooner by increasing the pace of drug development. Thank you very much for your continued support of RaQualia.

Jiangsu Meizheng Biotechnology Co., Ltd., established on 2014-03-20, The business scope includes biological detection reagents(Does not contain drugs,medical instruments)research and development,production and sales;Biotechnology Extension Services,technology development;Food Safety Testing Equipment,General Machinery,Professional setting,Instrumentation Design,to develop,Production,Sales,lease(Excluding finance lease);Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals)promotion of;IoT products,Network Information System,Computer hardware and software system design,to develop,Sales;Self-operated and agent import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of);technology transfer,technical consulting,Technical Services;Technical Training(Does not include certification,Does not include nationally recognized vocational certificate training);Food Testing Services;Design and Construction of Laboratory Decoration Project.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ionix Pharmaceuticals, based in Cambridge UK, is a leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain. Using proprietary drug targets and state-of-the-art chemistry, the company is developing medicines that are designed to alleviate pain associated with trauma, operative procedures, and debilitating diseases such as arthritis, diabetes and multiple sclerosis. Ionix Pharmaceuticals is a privately held company and was founded in 2001.

Zhongyang Biotechnology (Shanghai) Co., Ltd., established on 2018-12-29, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technology development in the field of biotechnology technology,technology transfer,technical consulting,Technical Services,Technology Exchange,Technology Promotion,Extraction of marine bioactive substances,purification,Synthesis technology research and development,Specialty Chemicals Sales(Free of Hazardous Chemicals),Cosmetic sales,Exhibition display service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dongxin Haote (Beijing) Biochemical Technology Co., Ltd., established on 2010-09-08, Business scope includes biochemistry,Medical Technology Development,technology transfer,technical consulting,Technical Services;Sales Class I,Class II medical device;Sales of Class III Medical Devices.(Enterprises independently choose operating projects according to law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Taizhou Kangte Biological Engineering Co., Ltd., established on 2001-07-05, Business scope includes biological products(Does not contain drugs)Production,Sales,Self-operated and agent import and export business of various commodities and technologies(Except for state restrictions on business operation and prohibition of import and export of commodities and technologies,It can only be operated after going through the licensing procedures involving national licensing operations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Orexa is a pharmaceutical company that provides therapeutics to increase food intake. Its main ingredient is a human-use oral formulation that is proprietary and based on a well-known anesthetic. The company's invention is based on several well-known anesthetics with a well-established safety profile. These anesthetics are typically administered by injection, but Orexa's research demonstrates that they can also be administered orally with a local mode of action.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Qingdao Qihao Nutrition Technology Co., Ltd., established on 2012-11-13, Business scope includes freshwater aquaculture and wholesale,retail;sell feed,feed ingredients,research and development,Sales of aquaculture equipment and related technical consulting services,Production of compound feed(Aquatic products),Sell ​​aquatic products,Sell ​​Feed Additives,research and development,Production and sales of probiotics,Aquaculture water conditioner(Does not contain chemical products and dangerous goods),Production and sales of pet feed,houses,Aquaculture Equipment Rental.(The above projects are engaged in business activities with the license issued by the competent industry department)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Bopunuo Technology Development Co., Ltd., established on 2015-11-02, Business scope includes medical technology,New Material Technology,Energy saving and environmental protection technology,Technology development in the field of chemical science and technology,technical consulting,Technical Services(remove human stem cells,Genetic Diagnosis and Therapy Technology),Pharmaceutical Intermediates,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Research and development of laboratory reagents and consumables,Sales,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Shengping Medical Equipment Co., Ltd., established on 2013-11-18, The scope of business includes the operation of medical equipment,Instrumentation,handcrafted gift,Daily necessities,household appliances,knitted goods,Stationery,building decoration materials(In addition to dangerous goods),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),computer(In addition to special products for computer information system security)Wholesale and retail;Self-owned medical equipment rental;medicine,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Yinian Biotechnology Co., Ltd., established on 2008-01-14, Business scope includes biotechnology(Except for special items)Technology development in the field of expertise,technology transfer,Technical Services,technical consulting,Market information consultation and investigation,Engaged in the import and export of goods and technology,sell electronics,Chemical products and raw materials(In addition to dangerous goods),medical instruments(one type),metallic material,steel,lubricating oil.(involving administrative licensing,The operating permit).

Jiangsu Huadu Pharmaceutical Co., Ltd., established on 2018-09-19, Business scope includes pharmaceuticals,food(Contains health food),Biological product(Contains tetrodotoxin)research and development,Production,Sales,technology transfer,Technical extension services;soap making,Production,Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Great Seven Bio-Technology Co., Ltd. engages in the production and sale of feeds. Its business activities include ordinary freight forwarding, breeding and sale of aquatic products, and sale of feeding materials. The company was founded on January 6, 2009 and is headquartered in Qingdao, China.